FF-you could be right. However, I don't think they want to put out any big news regarding cancer updates or other medical trial updates, until after they have laid a good financial picture "base" in the CC and after getting the long anticipated Haynes paper out of the way - if in fact it does actually come out in September's print issue of Nature Medicine as I am guessing.
No matter what way the Haynes paper's effect is, its going to have some effect (even if the effect is a flop due to the paper being a non-event) because PPHM placed so much effort into touting it - at least up until the last CC at which time it seemed to be absent from discussion.
Also, the CC is going to occur on 9-3 and the Haynes paper is projected (I'm only guessing here) to be coming out on 9-6. These both occur before a holiday shortened trading week.
I would expect the news you refer to will come out after the CC and after the holiday week. I believe that this allows people to get back from the summer vacations and get kids settled in school and then get prepared for some serious stock evaluation/trading/news assessment.
It also allows for some settling of a possible "non-event" Haynes paper impact.
Also, I believe that this prevents PPHM people from having to answer a bunch of detailed probing questions regarding the Haynes paper and any news releases. It also allows PPHM to control the news cycle regarding the projected news releases via PR releases.
Its seems obvious to me that they need to get started on raising the PPs before the NASDAQ deadline. I can't (don't want to) believe they would wait until the very last days in October to do it.
